Advanced Search

    Technical Analysis for TIL - Instil Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.85 -6.44% -0.06
    TIL closed down 6.44 percent on Wednesday, February 8, 2023, on 56 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical TIL trend table...
    Date Alert Name Type % Chg
    Overbought Stochastic Strength 0.00%
    MACD Bullish Centerline Cross Bullish -6.44%
    Upper Bollinger Band Walk Strength -6.44%
    Weak + Overbought Other -6.44%
    Gapped Up Strength -6.44%
    Overbought Stochastic Strength -6.44%
    Upper Bollinger Band Touch Strength -6.44%
    Upper Bollinger Band Walk Strength -6.85%
    Weak + Overbought Other -6.85%
    Wide Bands Range Expansion -6.85%
    Older End-of-Day Signals for TIL ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Fell Below 10 DMA about 8 hours ago
    10 DMA Support about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    Down 5% about 10 hours ago
    60 Minute Opening Range Breakdown about 11 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Cell Therapy Non Small Cell Lung Cancer Melanoma Lymphocytes Cervical Cancer Head And Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Cutaneous Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer Tumor Infiltrating Lymphocytes

    Is TIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 31 Instil Bio extends reduction-in-force to reduce US headcount
    Jan 31 Instil Bio Announces Extension of Cash Runway Beyond 2026 with the Consolidation of R&D Operations to its Manchester, U.K. Site
    Jan 9 Instil Bio Resumes ITIL-306 Study In Lung, Ovarian, Renal Cancers
    Jan 9 Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer
    Dec 13 Down 61.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
    Dec 9 Down 59.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Instil Bio, Inc. (TIL)
    Dec 8 Instil Bio Discontinues ITIL-168 Cancer Trials, Layoffs 60% Of Its Employees
    Dec 8 Instil Bio drops 11% as clinical priorities change
    Dec 8 Instil Bio Announces Prioritization of Genetically Engineered CoStAR-TIL Program with ITIL-306 in Advanced Solid Tumors and Reduction in Workforce
    Nov 15 Instil Bio GAAP EPS of -$0.43
    See more TIL news...

    Indicators

    Indicator Value
    52 Week High 13.01
    52 Week Low 0.471
    Average Volume 1,757,628
    200-Day Moving Average 4.18
    50-Day Moving Average 0.80
    20-Day Moving Average 0.81
    10-Day Moving Average 0.85
    Average True Range 0.08
    RSI 50.25
    ADX 25.71
    +DI 21.38
    -DI 14.15
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.87
    Upper Bollinger Bands 0.92
    Lower Bollinger Band 0.70
    Percent B (%b) 0.67
    BandWidth 27.16
    MACD Line 0.00
    MACD Signal Line -0.03
    MACD Histogram 0.0281
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.96
    Resistance 3 (R3) 0.97 0.94 0.94
    Resistance 2 (R2) 0.94 0.91 0.94 0.94
    Resistance 1 (R1) 0.89 0.89 0.88 0.88 0.93
    Pivot Point 0.86 0.86 0.85 0.86 0.86
    Support 1 (S1) 0.81 0.83 0.80 0.81 0.76
    Support 2 (S2) 0.78 0.81 0.78 0.75
    Support 3 (S3) 0.73 0.78 0.75
    Support 4 (S4) 0.73